ESR1 and breast cancer: An additional benefit of our chemoprevention modality is that it also has the potential to prevent both ER+ and ER- breast cancers, in contrast to current cancer prevention therapies that antagonize estrogen signaling and prevent ER+ breast cancer only [62].